<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="concerns about its toxicity halted its clinical development in the" exact="United States." post="Its metabolite, bromovinyluracil, irreversibly inhibits dihydropyridine dehydrogenase, which regulates"/>
 <result pre="recipients of kidney, heart, or kidney-pancreas transplants.61, 84 In the" exact="United States," post="valganciclovir is not approved for preventing CMV disease in"/>
</results>
